Use of at least one (dihydro)jasmonic acid derivative for treating dry skin

PHARMACEUTICAL FORMULATION FOR PARENTERAL ADMINISTRATION

Methods and compositions for treating platelet-related disorders

Systems and processes for spray drying hydrophobic and hydrophilic components

Lipoxin compounds and their use in treating cell proliferative disorders

USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF SMOOTH MUSCLE DISORDERS

Lipoxin compounds and their use in treating cell proliferative disorders

Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Methods of treating pain

Osteogenic and anti-adipogenic oxysterols

Method of enhancing hair growth

Method of inhibiting the emigration of cells from the intravascular compartment into tissues

Hypotensive lipid and timolol compositions and methods of using same

Enhanced bimatoprost ophthalmic solution

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING RETINAL DISEASES

Inhalation formulations of treprostinil

Prostaglandin analog compositions to treat epithelial-related conditions

Prostaglandin analog compositions and methods to treat epithelial-related conditions

Prostaglandin analog compositions to treat epithelial-related conditions

Prostaglandin analog compositions and methods to treat epithelial-related conditions

Prostaglandin analog compositions to treat epithelial-related conditions

Prostaglandin analog compositions and methods to treat epithelial-related conditions

Prostaglandin analog compositions to treat epithelial-related conditions

Prostaglandin analog compositions and methods to treat epithelial-related conditions

Prostaglandin analog compositions to treat epithelial-related conditions

Prostaglandin analog compositions and methods to treat epithelial-related conditions

Prostaglandin analog compositions to treat epithelial-related conditions

Prostaglandin analog compositions and methods to treat epithelial-related conditions

Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions

Technology for the Preparation of Microparticles

Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System

Epoprostenol formulation and method of making thereof

Method for placental exfoliation using oxo-arachidonic acid or the like

Methods of treating genitourinary disorders using inhibitors of soluble epoxide hydrolase

Methods for identifying and using IKK inhibitors

Use of a Fatty Acid Composition Containing DHA for the Production of a Medical Product or a Food Stuff for the Treatment of Amyloidos-Related Diseases

Polyamides

Methods and Compositions for Treatment of Erectile Dysfunction

Oral pharmaceutical dosage form and manufacturing method thereof

PHARMACEUTICAL COMBINATION OF NSAID AND PROSTAGLANDIN COMPOUND

Promoting wound healing by administering a prostaglandin E and granulocyte-macrophage colony stimulating factor

Method for the Prevention and/or Treatment of Neurodegenerative Diseases Characterized by Administering and Ep1 Receptor Antagonist

Inhibition of TNF-alpha-Initiated Response

TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA

Treatment and prevention of bone loss using resolvins

Treatment for Asthma and Arthritis and Other Inflammatory Diseases

Methods to increase or decrease bone density

Combined agents for treatment of glaucoma

Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

ANTAGONISTS OF PROSTAGLANDIN RECEPTORS EP2 AND/OR EP4 FOR THE TREATMENT OF DYSMENORRHEA AND MENORRHAGIA

TREPROSTINIL ADMINISTRATION USING A METERED DOSE INHALER

Vessel enlargement by arteriogenic factor delivery

Ointment

Compositions and methods for the treatment of inflammatory disease

Low temperature processes for making cyclic lipid implants for intraocular use

Intraocular drug delivery systems

Methods of treating an ocular allergy with low dose dexamethasone

Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2

Methods and compositions for treating platelet-related disorders

I kappa B kinase complex as a target for the treatment of Huntington's disease

Pharmaceutical compositions for the treatment of sexual disorders II

Methods and compositions for modulating the immune system and uses thereof

Inhibition of TNF-alpha-Initiated Neutrophil Response

Method of enhancing hair growth

Method for promoting gastrointestinal bicarbonate secretion

Pharmaceutical composition for treating fecal incontinence and anal itch

Prostamides for the treatment of glaucoma and related diseases

Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis

COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE

Method and composition for treating periodontal disease

Method of enhancing hair growth

Combinations of Hyaluronic Acid and Polyunsaturated Fatty Acids

COMPOSITIONS AND METHODS COMPRISING PROSTAGLANDIN-RELATED COMPOUNDS AND TREFOIL FACTOR FAMILY PEPTIDES FOR THE TREATMENT OF GLAUCOMA WITH REDUCED HYPEREMIA

Drug delivery methods, structures, and compositions for nasolacrimal system

Noninvasive angioplasty using momentary vacuum therapy

Osmotic drug delivery system

Synergistic Anti-Inflammatory Pharmaceutical Compositions and Methods of Use

Method of screening for a drug candidate that increases ATP release from RBCs stimulated via the Gs or Gi pathway

Pharmacological method for treatment of neuropathic pain

Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia

Nasolacrimal drainage system implants for drug therapy

Stable solutions of prostaglandin and uses of same

PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA

Methods, compositions, and kits for the treatment of medical conditions

ω-Cycloalkyl 17-heteroaryl prostaglandin Eanalogs as EP-receptor agonists

CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-THIOCARBAMOYLOXY AND 2-CARBAMOYLOXY COMPOUNDS AS THERAPEUTIC AGENTS

Methods and compositions for treating post-myocardial infarction damage

Rate controlled release of a pharmaceutical agent in a biodegradable device

Rate controlled release of a pharmaceutical agent in a biodegradable device

Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders

Stabilised prostaglandin composition

Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration

Hepoxilins and modulators of ichthyin for treatment skin disorders

METHODS OF TREATMENT FOR FEMALE SEXUAL AROUSAL DISORDER

Delayed release pharmaceutical oral dosage form and method of making same

Soft-gelatin capsule formulation

Delivery devices for hair-promoting cosmetic agent

(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure

Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions

Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation

THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS

Therapeutic methods using prostaglandin EPagonist components

Reproductive management

Compositions and methods of treatment

Use of an alkanoyl L-carnitine for the treatment of the erectile dysfunction

Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof

NOVEL PROSTAMIDES FOR THE TREATMENT OF GLAUCOMA AND RELATED DISEASES

Methods, compositions, and kits for the treatment of ophthalmic disorders

Compounds and compositions for delivering active agents

Compositions and methods for the intraocular transport of therapeutic agents

Methods to treat one or all of the defined etiologies of female sexual Dysfunction

Immunostimulatory nucleic acids for the treatment of asthma and allergy

Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Injectable Osteogenic Formula and Method of Using Same

Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same

Method for treating mucosal disorders

Uses of prostacyclin analogs

Stable prostaglandin-containing compositions

Agents and methods for enhancing bone formation

Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension

Method for treating peripheral vascular diseases

Cyclohexyl prostaglandin analogs as EP-receptor agonists

Selective androgen receptor modulators and methods of use thereof

Enhanced bimatoprost ophthalmic solution

Method for treating erectile dysfunction and increasing libido in men

Method for treating ocular hypertension and glaucoma

Method for treating central nervous system disorders

Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors

Methods for the treatment of infectious and inflammatory airway diseases

Use of docosahexanoic acid as active substance for the treatment of lipodystrophy

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

IMPROVED COX-2 INHIBITORY COMPOSITIONS AND THERAPEUTIC REGIMEN

Immunostimulatory nucleic acids for the treatment of asthma and allergy

Methods of using and compositions comprising PDE4 modulators for treatment, prevention and management airway inflammation

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation

Combination effective for the treatment of impotence

Methods for identifying IκB Kinase (IKK) inhibitors

Chloride channel opener

Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye

Novel inhibitors of ubiquitin isopeptidases

Combinations for the treatment of inflammatory skin disorders

Method of treating blepharospasm with a prostaglandin derivative

Drug for reducing side effects in ribavirin interferon combination therapy

Lipoxin compounds and their use in treating cell proliferative disorders

Stabilized leukotriene B(LTB) agent pharmaceutical formulation

Method for treating gastrointestinal disorder

I kappa B kinase complex as a target for the treatment of Huntington's disease

Method for preparing a polymer micelle pharmaceutical preparation containing drug for injection

Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia

Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists

Composition and method for the treatment of psoriasis

Method for identifying bronchoconstriction relaxing substances

Cyclohexyl prostaglandin analogs as EP-receptor agonists

Agents with leukotriene B-like antiviral (enveloped RNA) activities

Use of Treprostinil to treat neuropathic diabetic foot ulcers

Abnormal cannabidiols as agents for lowering intraocular pressure

Compositions comprising hepoxilin analogs and their use in the treatment of cancer

Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

Prostaglandin compounds for the treatment of obesity

Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase

Pharmaceutical compositions for the treatment of sexual disorders II

Methods to treat one or all of the defined etiologies of female sexual dysfunction

Methods and compositions for treating platelet-related disorders

Ophthalmic solution

Anti-constipation composition

Treatment of inflammatory bowel disease

Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

Combination therapy for glaucoma treatment

Mucoadhesive drug delivery devices and methods of making and using thereof

Dispersions prepared by use of self-stabilizing agents

Pharmaceuticals for xerosis

Synergistic anti-inflammatory pharmaceutical compositions and methods of use

Process for the preparation of alkylidenecyclopentanone derivatives

Topical stabilized prostaglandin E compound dosage forms

Methods and compositions for detecting and treating retinal diseases

Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss

Use of polyunsaturated ketones for the treatment of psoriasis

Use of treprostinil to treat and prevent ischemic lesions

Treatment of inflammatory bowel disease

Method for identifying bronchoconstriction relaxing substances

Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases

Lipoxin compounds and their use in treating cell proliferative disorders

Composition comprising an aqueous extract of red vine leaves and an antithrombotic agent

Pharmaceutical composition and method for treating hypogonadism

Method of inhibiting the emigration of cells from the intravascular compartment into tissues

Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent

Pharmaceutical composition and method for treating hypogonadism

Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

Pharmaceutical composition and method for treating hypogonadism

Prostamides for the treatment of glaucoma and related diseases

Use of orally available prostacyclin derivatives for the production of a pharmaceutical agent for treating diseases that are associated with bone marrow edemas

Compound for treatment of external secretion disorders

Method for treating or preventing inflammatory disorders

Use of alkanoyl l-carnitine for the treatment of erectile dysfunction

As-needed administration of an androgenic agent to enhance female desire and responsiveness

Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorphagia

Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides

Method for the treatment of glaucoma and ocular hypertension with prostaglandin analogues without melanogenic side effect

Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents

Method for treating erectile dysfunction and increasing libido in men

Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization

Medicinal products comprising prostaglandin compositions and methods of packaging such compositions

Method for treating erectile dysfunction and increasing libido in men

Cyclohexyl prostaglandin analogs as EP-receptor agonists

Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome

Combined agents for treatment of glaucoma

Method and composition for treating periodontal disease

Inhibitors of the anandamide transporter

Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2

Combined agents for treatment of glaucoma

Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug

Compositions and methods for amelioration of human female sexual dysfunction

Inhibition of irritating side effects associated with use of a topical ophthalmic medication

Oral allopregnanolone compositions and methods of use

Transdermal delivery of pharmaceutical agents

Compositions and methods for treatment of premature ejaculation

Composition having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction